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An 18-year-old girl—virgin, Indonesian, Bataknese, Moslem, student—was admitted to the Emergency Department of  
Haji Adam Malik Hospital, Medan, and presented with prolonged menstruation for the past 3 years, volume 5–6 pads/day,  
lasting for ±3 weeks, dark red, clotting (+), regular menstrual cycles. Vital signs were within normal limits. Physical  
examination revealed pale inferior conjunctiva palpebral and soft abdomen, with no palpable mass. As the patient was 
unmarried, speculum and vaginal examinations were not performed. This is apparently a sensitive issue as most eastern 
countries (including Indonesia), especially Muslim countries, highly value virginity. As the patient refused, a rectal toucher 
was also not used. Sonographic imaging revealed an anteflexed uterus measuring 7.1× 4.52 × 3.1 cm and endometrial 
thickness measuring 1.54 cm, suggestive of thickening endometrial wall. Both ovaries were normal sized. Based on these 
findings the patient was diagnosed with abnormal uterine bleeding and was subsequently administered with oral proges-
teron based on the recommended dose and duration of administration for three cycles.
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Three major categories of AUB have been proposed. They 
are the following:
Estrogen breakthrough bleeding: There will be intermittent 
spotting if estrogen level is low. But if estrogen level is high 
and for a long term, it will stimulate endometrium to proliferate 
continuously causing endometrium hyperplasia and eventually 
substantial bleeding.
Introduction
Abnormal uterine bleeding (AUB) is defined as uterine 
originated abnormal bleeding (quantity, frequency, and duration) 
occurring during or between menstrual cycles, the symptoms 
of which occur due to altered functional mechanism action 
of hypothalamic–pituitary–ovarian–endometrium axis without 
any organic reproductive abnormalities.[1,2]
AUB is the most common gynecologic symptom in 
reproductive-aged women in outpatient clinics with preva-
lence rates of 11 out of 13 women. This figure increases with 
age, reaching 25% in reproductive-aged women,[3] which is 
shown in Figure 1.[4]
AUB may be caused by estrogen withdrawal, foreign bodies, 
infection, sarcoma botryoides, ovarian tumor, trauma, and so 
on.[5] Figure 1: Population of abnormal uterine bleeding.[4]
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Estrogen withdrawal bleeding: Bleeding occurring after 
bilateral oophorectomy, radiation at mature follicles, or after 
cessation of estrogen therapy.
Progestin breakthrough bleeding: Bleeding occurring due 
to high progesterone and estrogen ratio. Lack of estrogen 
and progesterone therapy will induce spotting with variable 
duration. This bleeding is associated with the consumption of 
progestin, an oral contraceptive pill (OCP) for long periods; 
Norplant; and Depo-Provera.[1]
Etiology of Abnormal Uterine Bleeding based on age can 
be seen in Figure 2. FIGO in 2011 has proposed a classifica-
tion for AUB, which can be seen in Figure 3.
Figure 3: FIGO classification system 2011: abnormal uterine bleeding.[4]
Figure 2: Etiology of abnormal uterine bleeding.[5]
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Abnormal Uterine Bleeding in Perimenarche
Menstrual abnormalities are one of the major clinical 
mani festations in adolescents. Regular ovulation of menstrual 
cycles in adolescents occur every 21–35 days and last until 
7 days, with mean blood loss 25–69 mL. AUB in perimenarche 
can be caused by coagulopathy, immaturity of hypothalamus, 
insufficient luteal function, psychogenic disorder (such as 
bulimia and anorexia), and also ovarian tumor.[6]
Hereditary coagulopathy disorder is often a cause of AUB 
in adolescents. Von Willenbrand disease is the first etiology 
of AUB. Besides, AUB in perimenarche can also be caused 
by endocrinopathy (the most common example is thyroid 
disorder), systemic disease (such as blood dyscrasias: 
Immune Thrombocytopenic Purpura (ITP) and leukemia and 
chronic renal disease), and medicines (corticosteroids, psy-
chotropic drugs, anticoagulants, and herbs and plants: soy, 
ginseng, ginko).[7,8] Policystic ovarian syndrome (PCOS) is 
one of the causes of AUB in perimenarche. Clinical manifes-
tations of PCOS in adolescents are decreased birth weight, 
premature puberty, irregular menstruation (oligomenorrhea), 
hyperandrogen (hirsutism, acne, male-type baldness), obesity, 
family history of PCOS, diabetes mellitus type 2, premature 
cardiovascular disease.[8] While there are few uterine bleed-
ing causes in adolescents, most probable cause is AUB due 
to immature hypothalamic–pituitary–ovarian axis (HPO), 
causing irregular anovulatory cycle and bleeding. Before 
assuming HPO axis, clinicians must exclude more serious 
disorders.[9] Besides PCOS, AUB is often caused by endo-
metrial hyperplasia. It presents as AUB, often asymptomatic. 
Ultrasonography (USG) reveals endometrial hyperplasia. 
Endometrial hyperplasia diagnosis can be consi dered in 
patients complaining prolonged uterine bleeding or frequent 
bleeding.
When adolescents complain about AUB, history of men-
struation must be asked, including menarche age, duration, 
and the amount of uterine bleeding. Stomach cramps is a 
useful information. History of bleeding disorders in family and 
menstruation are very crucial.[9] Physical examination must 
encompass substantial signs and evaluate hyperandrogenism 
and bleeding signs. Sexual maturity scale assessment must 
be determined according to patients’ age. Nipple should be 
assessed for discharge. For majority of patients, mainly those 
who are not sexually active, internal pelvic examination will 
not be needed to evaluate pelvic anatomy. For those patients, 
USG might be enough for evaluating pelvic pathology. 
Laboratory assessment in adolescents with AUB also include 
pregnancy test, regardless of sexual activity history. After 
excluding pregnancy, practicians must consider additional 
tests to make differential diagnosis based on clinical mani-
festation. Complete blood count might help for evaluating 
anemia. American College of Obstetricians and Gynecol-
ogists (ACOG) recommend that all patients younger than 
18 years with AUB must be screened for coagulation disorders, 
particularly von Willebrand disease, because this disease has 
1% of prevalence and is the most common diseases causing 
menorrhagia in perimenarche.
Management of the problem in adolescents must be initi-
ated with looking for the cause, making pregnancy assessment, 
and blood coagulation disorders. If not one of these, then give 
OCP or norethindrone acetate therapy 5 g, as much as 
3 times a day for 7 days, and afterward reduce dosage until 
4 times in 3 weeks.[7]
Case Report
An 18-year-old female, virgo, Bataknese, Islam student 
admitted to the Emergency Department of Haji Adam Malik 
Hospital, Medan, with major complaint of prolonged men-
struation for approximately 3 years, with a volume resulting 
in 5–6 tampons/day, lasted for ±3 weeks, reddish black, 
clotting (+), regular menstruation cycle. Menarche at 13 years. 
Vital sign was normal. During general physical examination, 
pale conjunctiva palpebral inferior was noted and abdomen 
was lax. There were no symptoms of hyperandrogenic 
access. Abdominal wall was lax, no palpable mass was found. 
At gynecologic examination, clinician did not perform specu-
lum and vaginal examinations because the patient was not 
married. In Indonesia and other countries with Moslem majority, 
with Eastern cultures and customs, gynecologic examination 
including bimanual and speculum examinations are taboo and 
become controversial issue. Rectal toucher was not used in 
this case because the patient and her family refused it.
USG demonstrated normal-size anteflexi uterus 7.1 × 
4.52 × 3.1 cm with endometrial thickness 1.54 cm, suggestive 
of thickening endometrial wall.
From laboratory in Emergency Department:
Hemoglobin: 5.4 g/dL, Ht: 33.40%, Leucocyte: 10.760/mm3, 
Thrombocyte: 249.000/mm3, Ad Random Blood Glucose: 
109 mg/dL.
From anamnesis, physical examination, limited gyneco-
logic examination, laboratory test results, and other investi-
gations, thickening uterine wall was noted. Then, AUB M/AUB 
O/AUB M-O was performed as differential diagnosis for this 
patient, based on FIGO criteria to diagnose uterine bleeding 
disorder (AUB). This patient was given Progestin derivate, 
which is norethsterone (norethindron) 5 mg 2 × 1 tab for 10 days. 
Repeated again starting at day 16–25, in the next cycle with 
the same dose, then evaluated for 3–6 months.
Discussion
AUB is the most common gynecologic symptom in repro-
ductive-age women at outpatient clinics. This occurs in 11 
of 13 reproductive-age women. Its prevalence proportion-
ally increases with age, reaching 25% in reproductive-age 
women.
The main cause of AUB in adult is endometrial hyperplasia. 
Endometrial hyperplasia presents as AUB, often asymptomatic. 
USG reveals endometrial hyperplasia. Endometrial hyperplasia 
diagnosis can be considered in patients complaining pro-
longed uterine bleeding or frequent bleeding.
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When adolescents complain about AUB, history of men-
struation must be asked, including menarche age, duration, 
and amount of uterine bleeding. Stomach cramps is a useful 
information. History of bleeding disorders in family and men-
struation are very crucial. However, a comprehensive physi-
cal examination was not possible in this case. In Indonesia, 
where the majority of its population are Muslim, gynecological 
examination is a taboo for virgin or unmarried women. So in 
this case, endometrial biopsy was not performed to see histo-
pathologically what caused thickening in endometrial wall as 
seen in USG pictures.
AUB in perimenarche can be caused by coagulopathy, 
immaturity of hypothalamus, insufficient luteal function, psycho-
genic disorders (like bulimia and anorexia), and also ovarian 
tumor.[6] Hereditary coagulopathy disorder is often an AUB 
cause in adolescents. Von Willenbrand disease is the first 
etiology of AUB. Besides, AUB in perimenarche can also be 
caused by endocrinopathy (the most common example is 
thyroid disorder), systemic disease (such as blood dyscrasias: 
ITP and leukemia and chronic renal disease), medicines (corti-
costeroids, psychotropic drugs, anticoagulants, and herbs 
and plants: soy, ginseng, ginko).[7,8]
In this case, the diagnosis probably is AUB M based 
on 2011 FIGO criteria about classification of AUB, with some 
obstacles to establish this diagnosis due to customs and 
cultures. Hormonal therapy with norethisteron/norethindron is 
the right choice, because patient was not married and did not 
want to get pregnant, and after therapy menstruation became 
normal again.
Conclusion
Early diagnosis and right treatment are essential for AUB 
patients so that therapy will be given correctly. Customs, 
culture, and religion sometimes can be a challenge to 
conduct examinations. Despite a cure, the diagnosis 
and treatment sometimes raises controversy.
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